D. E. Shaw & Co., Inc. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,441,661
+104.6%
30,414
+223.6%
0.01%
+150.0%
Q2 2023$2,170,938
-68.8%
9,398
-67.3%
0.00%
-71.4%
Q1 2023$6,962,068
-84.4%
28,738
-81.3%
0.01%
-85.7%
Q4 2022$44,535,380
+2882.9%
153,438
+567.7%
0.05%
+2350.0%
Q3 2022$1,493,000
-6.0%
22,980
+3.6%
0.00%0.0%
Q2 2022$1,588,000
-28.9%
22,181
-2.6%
0.00%0.0%
Q1 2022$2,234,000
-18.9%
22,766
-29.9%
0.00%0.0%
Q4 2021$2,753,000
-28.5%
32,492
-32.6%
0.00%
-50.0%
Q3 2021$3,848,000
+25.8%
48,224
+53.5%
0.00%
+33.3%
Q2 2021$3,060,000
+127.2%
31,412
+172.7%
0.00%
+200.0%
Q1 2021$1,347,000
+217.7%
11,518
+201.8%
0.00%
Q4 2020$424,000
-53.5%
3,817
-61.8%
0.00%
-100.0%
Q4 2019$911,000
-53.8%
10,000
-56.3%
0.00%
-50.0%
Q3 2019$1,971,000
-51.3%
22,868
-40.8%
0.00%
-60.0%
Q2 2019$4,048,000
-13.8%
38,627
+3.1%
0.01%0.0%
Q1 2019$4,695,000
+69.3%
37,480
+52.4%
0.01%
+25.0%
Q4 2018$2,773,000
+240.7%
24,600
+547.4%
0.00%
+300.0%
Q3 2018$814,000
+142.3%
3,800
+216.7%
0.00%
Q2 2018$336,000
-93.2%
1,200
-97.2%
0.00%
-100.0%
Q1 2018$4,977,000
+117.0%
42,611
+70.5%
0.01%
+133.3%
Q4 2017$2,294,00024,9920.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HealthCor Management, L.P. 902,601$100,342,0003.87%
L1 Capital Pty Ltd 113,464$12,608,0002.35%
Avoro Capital Advisors LLC 1,225,000$136,183,0002.34%
Tao Capital Management LP 51,396$5,714,0001.40%
ARMISTICE CAPITAL, LLC 316,000$35,130,0001.20%
ACUTA CAPITAL PARTNERS, LLC 32,500$3,613,0000.98%
Capital Impact Advisors, LLC 24,351$2,707,0000.66%
Baker Brothers Advisors 1,499,213$166,668,0000.63%
Rock Springs Capital Management LP 256,768$28,545,0000.60%
SHIKIAR ASSET MANAGEMENT INC 12,000$1,334,0000.48%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders